Cover Image
Market Research Report

Europe Vascular Guidewires Market Forecast 2019-2027

Published by Inkwood Research Product code 904359
Published Content info 83 Pages
Delivery time: 2-3 business days
Price
Back to Top
Europe Vascular Guidewires Market Forecast 2019-2027
Published: August 7, 2019 Content info: 83 Pages
Description

KEY FINDINGS

As per Inkwood Research, the Europe vascular guidewires market accounted for XX% share in 2018. The market is anticipated to flourish with CAGR of 5.60% during the forecast period of 2019-2027. The prevalent cardiovascular diseases among the people, especially in the ageing population is driving the growth of vascular guidewires market in the region.

MARKET INSIGHTS

The vascular guidewires market in the Europe region is mainly influenced by the trends in economies like Spain, France, Germany, United Kingdom, Italy, and Rest of Europe regional segment that comprise other European countries. The well-equipped healthcare system with universal coverage and other facilities coupled with better medical equipment sector is impacting the vascular guidewires market in the countries of Spain & Italy. The high standard of living and high disposable income of people surges the demand for minimally invasive procedures that enables faster patients' recovery. As a result of this growing demand and technological advancements, the vascular guidewires market in the region will see an upward trend in the coming years.

COMPETITIVE INSIGHTS

Terumo, Cook Medical LLC, Olympus Corporation, GaltNeedleTech, Edward Lifesciences, Medtronic, Boston Scientific Corporation, Koninklijke Philips N.V., Merit Medical Systems, and Cardinal Health Inc., among others are some of the main players operating in the market. The strong position of these dominant companies with broad products portfolio poses an entry-level barrier for new entrants.

Table of Contents
Product Code: 26224

Table of contents

1. RESEARCH SCOPE

  • 1.1. STUDY GOALS
  • 1.2. SCOPE OF THE MARKET STUDY
  • 1.3. WHO WILL FIND THIS REPORT USEFUL?
  • 1.4. STUDY AND FORECASTING YEARS

2. RESEARCH METHODOLOGY

  • 2.1. SOURCES OF DATA
    • 2.1.1. SECONDARY DATA
    • 2.1.2. PRIMARY DATA
  • 2.2. TOP-DOWN APPROACH
  • 2.3. BOTTOM-UP APPROACH
  • 2.4. DATA TRIANGULATION

3. EXECUTIVE SUMMARY

  • 3.1. MARKET SUMMARY
  • 3.2. KEY FINDINGS
    • 3.2.1. CORONARY GUIDEWIRES ARE THE MAJORLY USED APPLICATION
    • 3.2.2. HYDROPHOBIC COATING IS THE FASTEST GROWING COATED TYPE
    • 3.2.3. HOSPITALS ARE THE HIGHEST REVENUE GENERATING END USERS

4. MARKET DYNAMICS

  • 4.1. MARKET SCOPE & DEFINITION
  • 4.2. MARKET DRIVERS
    • 4.2.1. RISE IN PREVALENCE OF CHRONIC DISEASES
    • 4.2.2. INCREASING DEMAND FOR MI PROCEDURES
    • 4.2.3. AWARENESS AMONG PATIENTS ABOUT TREATMENT OPTIONS
    • 4.2.4. PREVAILING HIGH UNMET MEDICAL NEEDS
  • 4.3. MARKET RESTRAINTS
    • 4.3.1. RISKS ASSOCIATED WITH THE USE OF GUIDEWIRES
    • 4.3.2. UNFAVORABLE PREFERENCE FOR DRUGS
    • 4.3.3. ISSUE IN LOST GUIDEWIRE RETRIEVAL
  • 4.4. MARKET OPPORTUNITIES
    • 4.4.1. TECHNOLOGICAL ADVANCEMENTS
    • 4.4.2. SURGE IN THE ADOPTION OF VASCULAR PROCEDURES
  • 4.5. MARKET CHALLENGES
    • 4.5.1. COMPLEXITIES ASSOCIATED IN THE MANUFACTURING OF VASCULAR GUIDEWIRES
    • 4.5.2. PRICING COUPLED WITH PAUCITY OF PRODUCT DIFFERENTIATION

5. MARKET BY APPLICATION

  • 5.1. CORONARY GUIDEWIRES
  • 5.2. PERIPHERAL GUIDEWIRES
  • 5.3. UROLOGICAL GUIDEWIRES
  • 5.4. NEUROVASCULAR GUIDEWIRES

6. MARKET BY COATING TYPE

  • 6.1. COATED
  • 6.2. NON-COATED

7. MARKET BY END USER

  • 7.1. HOSPITALS
  • 7.2. AMBULATORY SURGICAL CENTERS

8. KEY ANALYTICS

  • 8.1. PORTER'S FIVE FORCES MODEL
    • 8.1.1. THREAT OF NEW ENTRANTS
    • 8.1.2. THREAT OF SUBSTITUTE PRODUCTS
    • 8.1.3. BARGAINING POWER OF BUYER
    • 8.1.4. BARGAINING POWER OF SUPPLIER
    • 8.1.5. INTENSITY OF COMPETITIVE RIVALRY
  • 8.2. VALUE CHAIN ANALYSIS
  • 8.3. REGULATORY FRAMEWORK
  • 8.4. SUPPLY CHAIN ANALYSIS
  • 8.5. OPPORTUNITY MATRIX

9. GEOGRAPHICAL ANALYSIS

  • 9.1. EUROPE
    • 9.1.1. GERMANY
    • 9.1.2. FRANCE
    • 9.1.3. THE UNITED KINGDOM
    • 9.1.4. ITALY
    • 9.1.5. SPAIN
    • 9.1.6. REST OF EUROPE

10. COMPETITIVE LANDSCAPE

  • 10.1. MARKET SHARE ANALYSIS
  • 10.2. COMPANY PROFILES
    • 10.2.1. ABBOTT
    • 10.2.2. B BRAUN MELSUNGEN AG
    • 10.2.3. BECTON DICKINSON AND COMPANY
    • 10.2.4. BIOTRONIK SE & CO. KG
    • 10.2.5. BOSTON SCIENTIFIC CORPORATION
    • 10.2.6. CARDINAL HEALTH INC.
    • 10.2.7. COOK MEDICAL LLC
    • 10.2.8. EDWARD LIFESCIENCES
    • 10.2.9. GALTNEEDLETECH
    • 10.2.10. KONINKLIJKE PHILIPS N.V.
    • 10.2.11. MEDTRONIC
    • 10.2.12. MERIT MEDICAL SYSTEMS
    • 10.2.13. OLYMPUS CORPORATION
    • 10.2.14. TERUMO

LIST OF TABLES

  • TABLE 1 EUROPE VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
  • TABLE 2 MAJOR COMPLICATIONS CAUSED BY GUIDEWIRES DURING ENDOVASCULAR OR STENTING PROCEDURES
  • TABLE 3 EUROPE VASCULAR GUIDEWIRES MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 4 EUROPE CORONARY GUIDEWIRES MARKET 2019-2027 ($ MILLION)
  • TABLE 5 EUROPE PERIPHERAL GUIDEWIRES MARKET 2019-2027 ($ MILLION)
  • TABLE 6 EUROPE UROLOGICAL GUIDEWIRES MARKET 2019-2027 ($ MILLION)
  • TABLE 7 EUROPE NEUROVASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
  • TABLE 8 EUROPE COATED MARKET 2019-2027 ($ MILLION)
  • TABLE 9 EUROPE NON-COATED MARKET 2019-2027 ($ MILLION)
  • TABLE 10 EUROPE VASCULAR GUIDEWIRES MARKET BY END USER 2019-2027 ($ MILLION)
  • TABLE 11 EUROPE HOSPITALS MARKET 2019-2027 ($ MILLION)
  • TABLE 12 EUROPE AMBULATORY SURGICAL CENTERS MARKET 2019-2027 ($ MILLION)
  • TABLE 13 EUROPE VASCULAR GUIDEWIRES MARKET BY COUNTRY 2019-2027 ($ MILLION)
  • TABLE 14 GERMANY VASCULAR GUIDEWIRES MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 15 GERMANY VASCULAR GUIDEWIRES MARKET BY COATING TYPE 2019-2027 ($ MILLION)
  • TABLE 16 GERMANY VASCULAR GUIDEWIRES MARKET BY END USER 2019-2027 ($ MILLION)
  • TABLE 17 FRANCE VASCULAR GUIDEWIRES MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 18 FRANCE VASCULAR GUIDEWIRES MARKET BY COATING TYPE 2019-2027 ($ MILLION)
  • TABLE 19 FRANCE VASCULAR GUIDEWIRES MARKET BY END USER 2019-2027 ($ MILLION)
  • TABLE 20 THE UNITED KINGDOM VASCULAR GUIDEWIRES MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 21 THE UNITED KINGDOM VASCULAR GUIDEWIRES MARKET BY COATING TYPE 2019-2027 ($ MILLION)
  • TABLE 22 THE UNITED KINGDOM VASCULAR GUIDEWIRES MARKET BY END USER 2019-2027 ($ MILLION)
  • TABLE 23 ITALY VASCULAR GUIDEWIRES MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 24 ITALY VASCULAR GUIDEWIRES MARKET BY COATING TYPE 2019-2027 ($ MILLION)
  • TABLE 25 ITALY VASCULAR GUIDEWIRES MARKET BY END USER 2019-2027 ($ MILLION)
  • TABLE 26 SPAIN VASCULAR GUIDEWIRES MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 27 SPAIN VASCULAR GUIDEWIRES MARKET BY COATING TYPE 2019-2027 ($ MILLION)
  • TABLE 28 SPAIN VASCULAR GUIDEWIRES MARKET BY END USER 2019-2027 ($ MILLION)

LIST OF FIGURES

  • FIGURE 1 EUROPE VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
  • FIGURE 2 EUROPE VASCULAR GUIDEWIRES MARKET SHARE BY APPLICATION 2018 & 2027 (%)
  • FIGURE 3 EUROPE VASCULAR GUIDEWIRES MARKET BY CORONARY GUIDEWIRES 2019-2027 ($ MILLION)
  • FIGURE 4 EUROPE VASCULAR GUIDEWIRES MARKET BY PERIPHERAL GUIDEWIRES 2019-2027 ($ MILLION)
  • FIGURE 5 EUROPE VASCULAR GUIDEWIRES MARKET BY UROLOGICAL GUIDEWIRES 2019-2027 ($ MILLION)
  • FIGURE 6 EUROPE VASCULAR GUIDEWIRES MARKET BY NEUROVASCULAR GUIDEWIRES 2019-2027 ($ MILLION)
  • FIGURE 7 EUROPE VASCULAR GUIDEWIRES MARKET SHARE BY COATING TYPE 2018 & 2027 (%)
  • FIGURE 8 EUROPE VASCULAR GUIDEWIRES MARKET BY COATED 2019-2027 ($ MILLION)
  • FIGURE 9 EUROPE VASCULAR GUIDEWIRES MARKET BY NON-COATED 2019-2027 ($ MILLION)
  • FIGURE 10 EUROPE VASCULAR GUIDEWIRES MARKET SHARE BY END USER 2018 & 2027 (%)
  • FIGURE 11 EUROPE VASCULAR GUIDEWIRES MARKET BY HOSPITALS 2019-2027 ($ MILLION)
  • FIGURE 12 EUROPE VASCULAR GUIDEWIRES MARKET BY AMBULATORY SURGICAL CENTERS 2019-2027 ($ MILLION)
  • FIGURE 13 PORTER'S FIVE FORCE MODEL
  • FIGURE 14 GERMANY VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
  • FIGURE 15 FRANCE GERIATRIC POPULATION 2012 AND 2017 (MILLIONS)
  • FIGURE 16 FRANCE VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
  • FIGURE 17 THE UNITED KINGDOM VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
  • FIGURE 18 ITALY VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
  • FIGURE 19 SPAIN VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
  • FIGURE 20 REST OF EUROPE VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
Back to Top